CRF TCT 2022 Poster

crf_tct_logo

TCT 2022 Poster

Goldberg S et al.
2022

Baseline data

baseline_1
change_2d
change_3b

Survival

Looking into recently published survival with GDMT over 2 years, patients with a Carillon Mitral Contour System are doing as well as not having moderate/severe regurgitation. In comparison to other available treatment, the data indicated at least a similar outcome over 2 years.
recent_6
death_7